- Filed
- Jul 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 9, 2025 | 71.49M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $77.71M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $78.66M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $275.98M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $182.86M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $535.26M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $449.71M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $694.63M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $174.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $455.62M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.51B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.27B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 41.65M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $106K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.75M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$74.39M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$54.34M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.47 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $18.18M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.02M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$19.51M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$22.46M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $34.69M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $23.97M |
| Revenue | Q1 2025 · Mar 31, 2024 | $58.66M |